These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25373316)
21. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917 [TBL] [Abstract][Full Text] [Related]
22. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons. Desormeaux C; Bautzova T; Garcia-Caraballo S; Rolland C; Barbaro MR; Brierley SM; Barbara G; Vergnolle N; Cenac N Pain; 2018 Jul; 159(7):1257-1267. PubMed ID: 29554016 [TBL] [Abstract][Full Text] [Related]
23. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions. Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424 [TBL] [Abstract][Full Text] [Related]
24. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V. Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849 [TBL] [Abstract][Full Text] [Related]
25. PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways. Zhao J; Jin G; Liu X; Wu K; Yang Y; He Z; Liu D; Zhang C; Zhu D; Jiao J; Li X; Zhao S Cancer Cell Int; 2021 Nov; 21(1):637. PubMed ID: 34844621 [TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma. Li SM; Jiang P; Xiang Y; Wang WW; Zhu YC; Feng WY; Li SD; Yu GY Dongwuxue Yanjiu; 2014 Sep; 35(5):420-5. PubMed ID: 25297082 [TBL] [Abstract][Full Text] [Related]
27. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Vellani V; Kinsey AM; Prandini M; Hechtfischer SC; Reeh P; Magherini PC; Giacomoni C; McNaughton PA Mol Pain; 2010 Sep; 6():61. PubMed ID: 20875131 [TBL] [Abstract][Full Text] [Related]
28. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells. Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479 [TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. Hollenberg MD; Saifeddine M; Al-Ani B; Gui Y Can J Physiol Pharmacol; 1999 Jun; 77(6):458-64. PubMed ID: 10537233 [TBL] [Abstract][Full Text] [Related]
30. Activity of protease-activated receptors in the human submucous plexus. Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497 [TBL] [Abstract][Full Text] [Related]
31. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630 [TBL] [Abstract][Full Text] [Related]
33. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Vretenbrant K; Ramström S; Bjerke M; Lindahl TL Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509 [TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109 [TBL] [Abstract][Full Text] [Related]
35. Thrombin induces pro-inflammatory and anti-inflammatory cytokines secretion from human mast cell line (HMC-1) via protease-activated receptors. Fang X; Li M; Zhang W; Li J; Zhu T Mol Immunol; 2022 Jan; 141():60-69. PubMed ID: 34808483 [TBL] [Abstract][Full Text] [Related]
37. Characterization and functional activity of thrombin receptors in the human lens. James C; Collison DJ; Duncan G Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):925-32. PubMed ID: 15728549 [TBL] [Abstract][Full Text] [Related]
38. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization. Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114 [TBL] [Abstract][Full Text] [Related]
39. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724 [TBL] [Abstract][Full Text] [Related]
40. Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets. Han X; de la Fuente M; Nieman MT Res Pract Thromb Haemost; 2021 Jan; 5(1):104-110. PubMed ID: 33537534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]